DBV Technologies (DBVT) Operating Expenses (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Operating Expenses of $51.3 million for Q2 2026, up 20.42% year-on-year from $42.6 million in Q2 2025, and up 5.12% on a QoQ basis from $48.8 million in Q1 2026.

DBV Technologies (DBVT) Operating Expenses (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Operating Expenses for 7 consecutive years, with $51.3 million the latest figure, recorded in Q2 2026.

  • Quarterly Operating Expenses rose 20.42% year-over-year to $51.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $182.8 million (up 45.38% YoY) and the FY2025 annual result came in at $152.7 million, up 26.46% from the prior year.
  • Operating Expenses improved to $51.3 million in Q2 2026 per DBVT's latest filing, from $48.8 million in the prior quarter.
  • Over the last five years, Operating Expenses for DBVT reached as high as $51.3 million in Q2 2026 and fell as low as $19.3 million in Q1 2022.
  • A 5-year average of $31.5 million and a median of $28.7 million in 2024 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2022 — Operating Expenses surged 123.71% — and 2023, when it sank 43.36%.
  • Year by year, Operating Expenses stood at $36.7 million in 2022, then plunged by 43.36% to $20.8 million in 2023, then gained by 17.2% to $24.4 million in 2024, then jumped by 87.49% to $45.7 million in 2025, then grew by 12.27% to $51.3 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $51.3 million, $48.8 million, and $45.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -28.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.10 Bn
4 NuCana 279.75 Bn 279.75 Bn - -3.78 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 32.68 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 2.89 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 445.22 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 51.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 51.30 Mn
Mar 31, 2026 48.80 Mn
Dec 31, 2025 45.70 Mn
Sep 30, 2025 37.05 Mn
Jun 30, 2025 42.60 Mn
Mar 31, 2025 27.40 Mn
Dec 31, 2024 24.37 Mn
Sep 30, 2024 31.40 Mn
Jun 30, 2024 35.00 Mn
Mar 31, 2024 29.96 Mn
Dec 31, 2023 20.80 Mn
Sep 30, 2023 20.64 Mn
Jun 30, 2023 27.36 Mn
Mar 31, 2023 23.36 Mn
Dec 31, 2022 36.71 Mn
Sep 30, 2022 20.09 Mn
Jun 30, 2022 25.35 Mn
Mar 31, 2022 19.32 Mn
Dec 31, 2021 16.41 Mn
Sep 30, 2021 25.69 Mn